Human CellExp Renin, Human recombinant protein
Human Recombinant HIS-tagged Renin
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P00797 |
|---|---|
| Concentration | 0.74 |
| Calculated MW | 40 kDa (contains 8x HIS tag at the CT) |
| Gene ID | 5972 |
|---|---|
| Gene Symbol | REN |
| Other Names | Angiotensinogenase, REN. |
| Gene Source | Human |
| Source | Human Embryonic Kidney (HEK) cells |
| Assay&Purity | SDS-PAGE; ≥95% |
| Assay2&Purity2 | N/A; |
| Recombinant | Yes |
| Format | Liquid |
| Storage | -80°C; 0.74 mg/ml solution in 0.05M Tris-HCl and 0.05 M NaCl, pH 8.0 |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Renin is an aspartyl protease that is specific for only one substrate, angiotensinogen. Prorenin is a glycosylated aspartic protease that consists of 2 homologous lobes and is the precursor of renin. Prorenin exhibits a low level of enzymatic activity relative to renin. BioVision’s human renin is produced from the proenzyme prorenin by proteolytic cleavage of a 43 amino acid N-terminal prosegment using limited enzymatic digestion by immobilized trypsin and purified by affinity chromatography. Conversion to active renin is >99.99 percent.
References
Imai T.,et al.Proc. Natl. Acad. Sci. U.S.A. 80:7405-7409(1983).
Morris B.J.,et al.Clin. Sci. 71:345-355(1986).
Hardman J.A.,et al.DNA 3:457-468(1984).
Rieder M.J.,et al.Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
Ebert L.,et al.Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

